Gary Zieziula
Director/Board Member bij INNOVENT BIOLOGICS, INC.
Vermogen: 23 493 $ op 31-03-2024
Profiel
Gary J.
Zieziula currently works at Innovent Biologics, Inc., as Independent Non-Executive Director from 2022.
Mr. Zieziula also formerly worked at EMD Serono, Inc., as President & Managing Director, Bristol Myers Squibb Co., as VP-Sales & Cardiovascular Metabolic Products, Merck & Co., Inc., as Vice President-Sales, and AMAG Pharmaceuticals, Inc., as Chief Commercial Officer & Executive VP from 2010 to 2011.
Mr. Zieziula received his Masters Business Admin degree in 1983 from Canisius College and undergraduate degree in 1976 from State University of New York at Buffalo.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
INNOVENT BIOLOGICS, INC.
0.00% | 22-03-2024 | 4 877 ( 0.00% ) | 23 493 $ | 31-03-2024 |
Actieve functies van Gary Zieziula
| Bedrijven | Functie | Begin |
|---|---|---|
| INNOVENT BIOLOGICS, INC. | Director/Board Member | 31-05-2022 |
Eerdere bekende functies van Gary Zieziula
| Bedrijven | Functie | Einde |
|---|---|---|
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | President | 01-09-2018 |
| AMAG PHARMACEUTICALS, INC. | Corporate Officer/Principal | 04-11-2011 |
| MERCK & CO., INC. | Sales & Marketing | - |
| BRISTOL-MYERS SQUIBB COMPANY | Sales & Marketing | - |
Opleiding van Gary Zieziula
| Canisius College | Masters Business Admin |
| State University of New York at Buffalo | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| MERCK & CO., INC. | Health Technology |
| INNOVENT BIOLOGICS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
